SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (1618)6/5/2003 9:11:40 PM
From: Miljenko Zuanic  Read Replies (3) of 3044
 
<<Some miracle drugs emerge from eureka moments, but more often a new compound results from years of meticulous, plodding work championed by a relentless true believer. And so it is for a drug approved last month to treat a deadly cancer of the blood known as multiple myeloma.>>

I am one who believes in deep, broad, basic science. Without it there is no new breaktrue drugs. Unless you are lucky. And, MLNM was lucky with Velcade.

Now they are restructuring to generate profitability, down the road. This is OK, but what will prevail and what not is not clear to me? AMGN didn't done anything for 10 years, but was extremely lucky with two drugs. They changed philosophy last year. DNA was silent and busy for years, building foundation on its own resource and scraping candidates of interest. What business model is Levin building? Or MLNM is for sale, down the road?

Miljenko
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News